Gavin Spencer

Gavin Spencer is a seasoned executive with extensive experience in the pharmaceutical and ophthalmic industries, currently serving as the Chief Executive Officer at Nicox since February 2005. Under Gavin Spencer's leadership, Nicox has undergone significant restructuring to optimize its focus on clinical assets and future strategies. Prior roles include Executive Vice President and Chief Business Officer, where responsibilities encompassed corporate development, investor relations, and strategic planning. Additionally, Gavin Spencer has provided business advice to Parkure, a company dedicated to finding a cure for Parkinson’s disease, and has served on the boards of various organizations such as Altacor. Educational qualifications include a Bachelor’s Degree and a Doctor of Philosophy in Chemistry from the University of Aberdeen.